QUARTERLY REPORT

Q2 2026 — Form 10-Q

Q2 2026PDF · 38 pages579 KB
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________________________
FORM 10-Q
_________________________________________________________
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2026
- OR -
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission file number 001-31553
CME GROUP INC.
(Exact name of registrant as specified in its charter)
Delaware 	36-4459170
(State or other jurisdiction of
incorporation or organization) (I.R.S. Employer
Identification No.)
20 South Wacker Drive 	Chicago 	Illinois 	60606
(Address of principal executive offices) 	(Zip Code)
(312) 930-1000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading symbol 	Name of each exchange on which registered
Class A Common Stock 	CME 	The Nasdaq Stock Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. 	Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files). 	Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth
company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
The number of shares outstanding of each of the registrant’s classes of common stock as of July 8, 2026 was as follows: 359,576,125 shares of Class A
common stock, $0.01 par value; 625 shares of Class B-1 common stock, $0.01 par value; 813 shares of Class B-2 common stock, $0.01 par value; 1,287
shares of Class B-3 common stock, $0.01 par value; and 413 shares of Class B-4 common stock, $0.01 par value.
1

-- 1 of 38 --

Table of Contents
CME GROUP INC.
FORM 10-Q
INDEX
Page
PART I. FINANCIAL INFORMATION 	3
Item 1. 	Financial Statements 	5
Consolidated Balance Sheets at June 30, 2026 and December 31, 2025 	5
Consolidated Statements of Income for the Quarters and Six Months Ended June 30, 2026 and 2025 	6
Consolidated Statements of Comprehensive Income for the Quarters and Six Months Ended June 30, 2026 and 2025 	7
Consolidated Statements of Equity for the Quarters and Six Months Ended June 30, 2026 and 2025 	8
Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2026 and 2025 	10
Notes to Unaudited Consolidated Financial Statements 	12
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	23
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	32
Item 4. 	Controls and Procedures 	32
PART II. OTHER INFORMATION 	32
Item 1. 	Legal Proceedings 	32
Item 1A. 	Risk Factors 	32
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	33
Item 5. 	Other Information 	33
Item 6. 	Exhibits 	34
SIGNATURES 	35
2

-- 2 of 38 --

Table of Contents
PART I. FINANCIAL INFORMATION
Certain Terms
All references to “options” or “options contracts” in the text of this document refer to options on futures contracts.
Further information about CME Group and its products can be found at http://www.cmegroup.com. Information made available on our website does not
constitute a part of this Quarterly Report on Form 10-Q.
Information about Contract Volume and Average Rate per Contract
Unless otherwise noted, all amounts regarding contract volume and average rate per contract are for CME Group's listed futures and options on futures
contracts and exclude CME Group's event contracts.
Trademark Information
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. (CME),
CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort
are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec
Americas LLC and EBS is a trademark of EBS Group Limited. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or
trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P Dow Jones Indices LLC, as the case may be, and
have been licensed for use by CME. All other trademarks are the property of their respective owners.
Forward-Looking Statements
From time to time, in this Quarterly Report on Form 10-Q as well as in other written reports and verbal statements, we discuss our expectations regarding
future performance. These forward-looking statements are identified by their use of terms and phrases such as “believe,” “anticipate,” “could,” “estimate,”
“intend,” “may,” “plan,” “expect” and similar expressions, including references to assumptions. These forward-looking statements are based on currently
available competitive, financial and economic data, current expectations, estimates, forecasts and projections about the industries in which we operate and
management's beliefs and assumptions. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are
difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We
want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are:
• increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of
existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development,
implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such
technology is not vulnerable to security risks;
• our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our
electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the
competitiveness of our existing products and services;
• our ability to adjust our fixed costs and expenses if our revenues decline;
• our ability to manage variable costs associated with CME Group's transition to the Google Cloud, and minimizing the duplicative costs of
maintaining both on-premise and Google Cloud environments during the transition;
• the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of
cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers;
• our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers;
• our ability to expand and globally offer our products and services;
• changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our
industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as
well as the impact of tariffs and tax policy changes, restrictions on our ability to offer CME Group products and services in specific geographies or
to specific customers or limitations or changes in underlying/physical product flows across geographies;
• the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual
property rights of others;
• decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions;
3

-- 3 of 38 --

Table of Contents
• changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer
receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure;
• the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing firms and other
counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business;
• the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors
and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets;
• our dependence on third-party providers and exposure to risk from third parties, including risks related to the performance, reliability and security
of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on;
• our reliance on third-party distribution partners, including independent software vendors (ISVs), futures commission merchants (FCMs),
introducing brokers, broker-dealers, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading
and for market data information, and potential impacts from changes in their business models and priorities;
• volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity
indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the
capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers;
• our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability
to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our
trading and clearing systems;
• our ability to execute our growth strategy and maintain our growth effectively;
• our ability to manage the risks, control the costs and achieve the synergies associated with and benefits from our strategy for acquisitions,
investments, alliances, strategic partnerships and joint ventures;
• variances in earnings on cash accounts and collateral that our clearing house holds;
• impact of CME Group pricing/fee level and structure and incentive changes;
• impact of aggregation services and internalization on trade flow and volumes;
• any negative financial impacts from changes to the terms of intellectual property and index rights;
• our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business;
• industry, channel partner and customer consolidation and/or concentration;
• decreases in trading and clearing activity;
• the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions;
• increases in effective tax rates, borrowing costs or changes in tax policy;
• our ability to maintain our brand and reputation; and
• the unfavorable resolution of material legal proceedings.
For a detailed discussion of these and other factors that might affect our performance, see Item 1A. of our Annual Report on Form 10-K for the year ended
December 31, 2025, filed with the Securities and Exchange Commission on February 26, 2026 and Item 1A. in Part II of this Quarterly Report on Form 10-
Q.
4

-- 4 of 38 --

Table of Contents
ITEM 1. 	FINANCIAL STATEMENTS
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(dollars in millions, except par value data; shares in thousands)
June 30, 2026 	December 31, 2025
(unaudited)
Assets
Current Assets:
Cash and cash equivalents 	$ 	2,144.2 $ 	4,416.9
Marketable securities 	131.4 	125.0
Accounts receivable, net of allowance of $9.1 and $10.0 	753.1 	639.2
Other current assets (includes $4.4 and $6.5 in restricted cash) 	491.7 	522.1
Performance bonds and guaranty fund contributions 	158,110.7 	159,656.1
Total current assets 	161,631.1 	165,359.3
Property, net of accumulated depreciation and amortization of $993.7 and $1,005.7 	351.2 	362.7
Intangible assets—trading products 	17,175.3 	17,175.3
Intangible assets—other, net 	2,494.6 	2,610.7
Goodwill 	10,505.8 	10,514.7
Other assets 	2,518.6 	2,401.5
Total Assets 	$ 	194,676.6 $ 	198,424.2
Liabilities and Equity
Current Liabilities:
Accounts payable 	$ 	68.0 $ 	71.8
Other current liabilities 	538.6 	568.8
Performance bonds and guaranty fund contributions 	158,110.7 	159,656.1
Total current liabilities 	158,717.3 	160,296.7
Long-term debt 	3,424.2 	3,422.3
Deferred income tax liabilities, net 	5,220.9 	5,242.2
Other liabilities 	793.8 	734.8
Total Liabilities 	168,156.2 	169,696.0
Shareholders’ Equity:
Preferred stock, $0.01 par value, 10,000 shares authorized at June 30, 2026 and December 31, 2025;
no shares issued and outstanding as of June 30, 2026 and 4,584 issued and outstanding as of
December 31, 2025 	— 	—
Class A common stock, $0.01 par value, 1,000,000 shares authorized at June 30, 2026 and
December 31, 2025; 359,275 and 358,950 shares issued and outstanding as of June 30, 2026 and
December 31, 2025, respectively 	3.6 	3.6
Class B common stock, $0.01 par value, 3 shares authorized, issued and outstanding as of June 30,
2026 and December 31, 2025 	— 	—
Additional paid-in capital 	21,004.4 	22,209.5
Retained earnings 	5,457.5 	6,433.2
Accumulated other comprehensive income (loss) 	54.9 	81.9
Total CME Group Shareholders’ Equity 	26,520.4 	28,728.2
Total Liabilities and Equity 	$ 	194,676.6 $ 	198,424.2
See accompanying notes to unaudited consolidated financial statements.
5

-- 5 of 38 --

Table of Contents
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(dollars in millions, except per share data; shares in thousands)
(unaudited)
Quarter Ended 	Six Months Ended
June 30, 	June 30,
2026 	2025 	2026 	2025
Revenues
Clearing and transaction fees 	$ 	1,352.5 $ 	1,388.0 $ 	2,895.1 $ 	2,725.3
Market data and information services 	238.1 	198.1 	462.2 	392.6
Other 	115.6 	105.9 	229.0 	216.4
Total Revenues 	1,706.2 	1,692.0 	3,586.3 	3,334.3
Expenses
Compensation and benefits 	233.5 	221.6 	456.5 	428.3
Technology 	83.3 	70.9 	159.9 	136.6
Professional fees and outside services 	29.1 	37.4 	57.3 	65.9
Amortization of purchased intangibles 	56.0 	56.1 	112.1 	111.3
Depreciation and amortization 	28.2 	27.3 	55.4 	54.6
Licensing and other fee agreements 	109.1 	96.2 	215.9 	192.8
Other 	59.9 	53.2 	112.4 	107.5
Total Expenses 	599.1 	562.7 	1,169.5 	1,097.0
Operating Income 	1,107.1 	1,129.3 	2,416.8 	2,237.3
Non-Operating Income (Expense)
Investment income 	1,429.7 	1,518.4 	2,819.0 	2,411.1
Interest and other borrowing costs 	(43.6) 	(44.0) 	(87.2) 	(85.7)
Equity in net earnings of unconsolidated subsidiaries 	97.7 	99.0 	200.1 	187.2
Other non-operating income (expense) 	(1,263.2) 	(1,372.4) 	(2,510.1) 	(2,174.8)
Total Non-Operating Income (Expense) 	220.6 	201.0 	421.8 	337.8
Income before Income Taxes 	1,327.7 	1,330.3 	2,838.6 	2,575.1
Income tax provision 	285.9 	305.2 	642.5 	593.8
Net Income 	$ 	1,041.8 $ 	1,025.1 $ 	2,196.1 $ 	1,981.3
Earnings per Share Attributable to Common Shareholders of CME
Group:
Basic 	$ 	2.89 $ 	2.81 $ 	6.11 $ 	5.44
Diluted 	2.88 	2.81 	6.06 	5.43
Weighted Average Number of Common Shares:
Basic 	360,684 	359,658 	360,005 	359,636
Diluted 	361,282 	360,355 	362,233 	360,297
See accompanying notes to unaudited consolidated financial statements.
6

-- 6 of 38 --

Table of Contents
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)
(unaudited)
Quarter Ended 	Six Months Ended
June 30, 	June 30,
2026 	2025 	2026 	2025
Net Income 	$ 	1,041.8 $ 	1,025.1 $ 	2,196.1 $ 	1,981.3
Other comprehensive income (loss), net of tax:
Investment securities:
Net unrealized holding gains (losses) arising during the period 	— 	(0.1) 	(0.1) 	0.1
Investment securities, net 	— 	(0.1) 	(0.1) 	0.1
Defined benefit plans:
Net change in defined benefit plans arising during the period 	(0.1) 	— 	(2.2) 	(1.2)
Amortization of net actuarial (gains) losses included in compensation
and benefits expense 	(0.1) 	(0.1) 	(0.1) 	(0.1)
Income tax benefit (expense) 	0.1 	— 	0.5 	0.3
Defined benefit plans, net 	(0.1) 	(0.1) 	(1.8) 	(1.0)
Derivative investments:
Reclassification of net unrealized (gains) losses to interest expense and
other non-operating income (expense) 	(1.0) 	(1.1) 	(2.1) 	(2.0)
Income tax benefit (expense) 	0.2 	0.3 	0.5 	0.5
Derivative investments, net 	(0.8) 	(0.8) 	(1.6) 	(1.5)
Foreign currency translation:
Foreign currency translation adjustments 	(4.7) 	128.7 	(26.6) 	164.3
Income tax benefit (expense) 	1.1 	(7.5) 	3.1 	(11.0)
Foreign currency translation, net 	(3.6) 	121.2 	(23.5) 	153.3
Other comprehensive income (loss), net of tax 	(4.5) 	120.2 	(27.0) 	150.9
Comprehensive Income 	$ 	1,037.3 $ 	1,145.3 $ 	2,169.1 $ 	2,132.2
See accompanying notes to unaudited consolidated financial statements.
7

-- 7 of 38 --

Table of Contents
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY
(dollars in millions, except per share data; shares in thousands)
(unaudited)
Six Months Ended, June 30, 2026
Preferred
Stock
(Shares)
Class A
Common
Stock
(Shares)
Class B
Common
Stock
(Shares)
Preferred
Stock, Common
Stock and
Additional
Paid-in
Capital Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total CME Group
Shareholders’
Equity
Balance at December 31, 2025 	4,584 	358,950 	3 $ 22,213.1 $ 6,433.2 $ 	81.9 $ 	28,728.2
Net income 	2,196.1 	2,196.1
Other comprehensive income (loss) 	(27.0) 	(27.0)
Dividends on common stock of $8.75 per share 	(3,171.8) 	(3,171.8)
Conversion of Series G preferred stock to Class
A common stock 	(4,584) 	4,584
Vesting of issued restricted Class A common
stock 	96 	(22.2) 	(22.2)
Shares issued to Board of Directors 	14 	3.1 	3.1
Shares issued under Employee Stock Purchase
Plan 	16 	4.3 	4.3
Repurchase of Class A common stock 	(4,385) 	(1,236.9) 	(1,236.9)
Stock-based compensation 	46.6 	46.6
Balance at June 30, 2026 	— 	359,275 	3 $ 21,008.0 $ 5,457.5 $ 	54.9 $ 	26,520.4
Quarter Ended, June 30, 2026
Preferred
Stock
(Shares)
Class A
Common
Stock
(Shares)
Class B
Common
Stock
(Shares)
Preferred
Stock, Common
Stock and
Additional
Paid-in
Capital Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total CME Group
Shareholders’
Equity
Balance at March 31, 2026 	— 	361,790 	3 $ 21,674.2 $ 4,884.6 $ 	59.4 $ 	26,618.2
Net income 	1,041.8 	1,041.8
Other comprehensive income (loss) 	(4.5) 	(4.5)
Dividends on common stock of $1.30 per share 	(468.9) 	(468.9)
Vesting of issued restricted Class A common
stock 	1 	(0.2) 	(0.2)
Shares issued to Board of Directors 	14 	3.1 	3.1
Shares issued under Employee Stock Purchase
Plan 	16 	4.3 	4.3
Repurchase of Class A common stock 	(2,546) 	(698.2) 	(698.2)
Stock-based compensation 	24.8 	24.8
Balance at June 30, 2026 	— 	359,275 	3 $ 21,008.0 $ 5,457.5 $ 	54.9 $ 	26,520.4
In December 2024, the board of directors approved a share repurchase program (the Share Repurchase Program), which authorizes the repurchase of up to $3.0 billion of CME Group Class A
common stock at prevailing market prices. During the three and six months ended June 30, 2026, 2,546,284 and 4,384,776 shares of outstanding Class A common stock were repurchased,
respectively. The average price was $273.14 per share for a total of $0.7 billion (excluding excise tax) during the second quarter of 2026 and $280.87 per share for a total of $1.2 billion
(excluding excise tax) for the first six months of 2026. The remaining aggregate amount under the existing Share Repurchase Program is $1.5 billion. Shares are retired upon repurchase and not
held as treasury stock.
(1)
(1)
(1)
8

-- 8 of 38 --

Table of Contents
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY
(dollars in millions, except per share data; shares in thousands)
(unaudited)
Six Months Ended, June 30, 2025
Preferred
Stock
(Shares)
Class A
Common
Stock
(Shares)
Class B
Common
Stock
(Shares)
Preferred Stock,
Common
Stock and
Additional
Paid-in
Capital Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total CME Group
Shareholders’
Equity
Balance at December 31, 2024 	4,584 	359,602 	3 $ 22,406.6 $ 4,185.8 $ 	(105.5) $ 	26,486.9
Net income 	1,981.3 	1,981.3
Other comprehensive income (loss) 	150.9 	150.9
Dividends on common and preferred stock of
$2.50 per share 	(912.2) 	(912.2)
Vesting of issued restricted Class A common
stock 	50 	(8.8) 	(8.8)
Shares issued to Board of Directors 	11 	3.0 	3.0
Shares issued under Employee Stock Purchase
Plan 	16 	4.2 	4.2
Repurchase of Class A common stock 	(32) 	(8.2) 	(8.2)
Stock-based compensation 	41.9 	41.9
Balance at June 30, 2025 	4,584 	359,647 	3 $ 22,438.7 $ 5,254.9 $ 	45.4 $ 	27,739.0
Quarter Ended, June 30, 2025
Preferred
Stock
(Shares)
Class A
Common
Stock
(Shares)
Class B
Common
Stock
(Shares)
Preferred
Stock, Common
Stock and
Additional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total CME Group
Shareholders’
Equity
Balance at March 31, 2025 	4,584 	359,646 	3 $ 22,419.6 $ 4,685.9 $ 	(74.8) $ 	27,030.7
Net income 	1,025.1 	1,025.1
Other comprehensive income (loss) 	120.2 	120.2
Dividends on common and preferred stock of
$1.25 per share 	(456.1) 	(456.1)
Vesting of issued restricted Class A common
stock 	6 	(0.6) 	(0.6)
Shares issued to Board of Directors 	11 	3.0 	3.0
Shares issued under Employee Stock Purchase
Plan 	16 	4.2 	4.2
Repurchase of Class A common stock 	(32) 	(8.2) 	(8.2)
Stock-based compensation 	20.7 	20.7
Balance at June 30, 2025 	4,584 	359,647 	3 $ 22,438.7 $ 5,254.9 $ 	45.4 $ 	27,739.0
In December 2024, the board of directors approved a share repurchase program (the Share Repurchase Program), which authorizes the repurchase of up to $3.0 billion of CME Group Class A
common stock at prevailing market prices. During the three and six months ended June 30, 2025, 32,265 shares of outstanding Class A common stock were repurchased at an average price of
$253.05 per share for a total of $8.2 million The remaining aggregate amount under the existing Share Repurchase Program is $3.0 billion. Shares are retired upon repurchase and not held as
treasury stock.
See accompanying notes to unaudited consolidated financial statements.
(1)
(1)
(1)
9

-- 9 of 38 --

Table of Contents
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
Six Months Ended
June 30,
2026 	2025
Cash Flows from Operating Activities
Net income 	$ 	2,196.1 $ 	1,981.3
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation 	46.6 	41.9
Amortization of purchased intangibles 	112.1 	111.3
Depreciation and amortization 	55.4 	54.6
Net realized and unrealized (gains) losses on investments 	19.1 	(2.6)
Deferred income taxes 	(8.2) 	(20.7)
Change in:
Accounts receivable 	(112.9) 	(95.4)
Other current assets 	37.8 	(24.6)
Other assets 	(141.9) 	29.8
Accounts payable 	(3.8) 	12.5
Income taxes payable 	(40.4) 	28.3
Other current liabilities 	(49.4) 	67.9
Other liabilities 	113.4 	(9.2)
Other 	(16.9) 	—
Net Cash Provided by Operating Activities 	2,207.0 	2,175.1
Cash Flows from Investing Activities
Proceeds from maturities of available-for-sale marketable securities 	2.0 	4.8
Purchases of available-for-sale marketable securities 	(2.2) 	(3.8)
Purchases of property, net (45.4) 	(32.6)
Investments in privately-held equity investments 	(6.8) 	(2.4)
Net Cash Used in Investing Activities 	(52.4) 	(34.0)
Cash Flows from Financing Activities
Proceeds from debt, net of issuance costs 	— 	742.3
Repayment of debt 	— 	(750.0)
Cash dividends 	(3,165.7) 	(3,022.7)
Repurchase of Class A common stock, including costs 	(1,236.9) 	(8.2)
Change in performance bond and guaranty fund contributions 	(1,545.4) 	43,262.5
Employee taxes paid on restricted stock vesting 	(22.2) 	(8.8)
Other 	(4.6) 	(4.5)
Net Cash (Used in) Provided by Financing Activities 	(5,974.8) 	40,210.6
10

-- 10 of 38 --

Table of Contents
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(in millions)
(unaudited)
Six Months Ended
June 30,
2026 	2025
Net change in cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	(3,820.2) $ 	42,351.7
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period 	164,079.5 	101,794.1
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period 	$ 	160,259.3 $ 	144,145.8
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents:
Cash and cash equivalents 	$ 	2,144.2 $ 	1,981.3
Short-term restricted cash 	4.4 	6.5
Restricted cash and restricted cash equivalents (performance bonds and guaranty fund contributions) 	158,110.7 	142,158.0
Total 	$ 	160,259.3 $ 	144,145.8
Supplemental Disclosure of Cash Flow Information
Income taxes paid, net of refunds 	$ 	689.7 $ 	579.6
Interest paid 	70.2 	65.0
See accompanying notes to unaudited consolidated financial statements.
11

-- 11 of 38 --

Table of Contents
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
The consolidated financial statements consist of CME Group Inc. (CME Group) and its subsidiaries (collectively, the company), including Chicago
Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), Commodity
Exchange, Inc. (COMEX) and NEX Group Limited (NEX). The clearing house is operated by CME.
The accompanying interim consolidated financial statements have been prepared by CME Group without audit. Certain notes and other information
normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed
or omitted. In the opinion of management, the accompanying consolidated financial statements include all adjustments (consisting only of normal recurring
adjustments) considered necessary to present fairly the financial position of the company at June 30, 2026 and December 31, 2025 and the results of
operations and cash flows for the periods indicated. Quarterly results are not necessarily indicative of results for any subsequent period.
The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in CME
Group’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (SEC) on February 26,
2026.
2. Accounting Policies
Newly Adopted Accounting Policies. In July 2025, the FASB issued an accounting standards update which provides a practical expedient when estimating
the amount of expected credit losses on current accounts receivable and current contract assets. This update permits entities to assume that current
conditions as of the balance sheet date do not change for the remaining life of the current accounts receivable and current contract assets. Therefore, entities
will not need to develop reasonable and supportable forecasts of future economic conditions. The practical expedient must be applied consistently across all
current accounts receivable and current contract assets. The company adopted this standard on January 1, 2026, and has elected to apply the practical
expedient. The adoption of this guidance did not have a material impact on our consolidated financial statements.
3. Revenue Recognition
The company generates revenue from customers from the following sources:
Clearing and transaction fees. Clearing and transaction fees include per-contract charges for trade matching, clearing, trading on the company's electronic
trading platforms, portfolio reconciliation and compression services, risk mitigation, and other fees. Clearing and transaction fees are assessed upfront at
the time of trade execution. As such, the company recognizes the majority of the fee revenue upon successful execution of the trade. The minimal
remaining portion of the fee revenue related to settlement activities performed after trade execution is recognized over the short-term period that the
contract is outstanding, based on management’s estimates of the average contract lifecycle. These estimates are based on various assumptions to
approximate the amount of fee revenue to be attributed to services performed through contract settlement, expiration, or termination. For cleared trades,
these assumptions include the average number of days that a contract remains in open interest, contract turnover, average revenue per day, and revenue
remaining in open interest at the end of each period.
The nature of contracts gives rise to several types of variable consideration, including volume-based pricing tiers, customer incentives associated with
market maker programs and other fee discounts. The company includes fee discounts and incentives in the estimated transaction price when there is a basis
to reasonably estimate the amount of the fee reduction. These estimates are based on historical experience, anticipated performance, and best judgment at
the time. Because of the company's certainty in estimating these amounts, they are included in the transaction price of contracts.
Market data and information services. Market data and information services represent revenue from the dissemination of market data to subscribers,
distributors, and other third-party licensees of market data. Pricing for market data is primarily based on the number of reportable devices used as well as
the number of subscribers enrolled under the arrangement. Fees for these services are generally billed monthly. Market data services are satisfied over time
and revenue is recognized on a monthly basis as the customers receive and consume the benefit of the market data services. However, the company also
maintains certain annual license arrangements with one-time upfront fees. The fees for annual licenses are initially recorded as a contract liability and
recognized as revenue monthly over the term of the annual period.
Other. Other revenues include certain access and communication fees, fees for collateral management, equity membership subscription fees, and fees for
trade order routing through agreements from various strategic relationships. Access and communication fees are charged to customers that utilize various
telecommunications networks and communications services. Fees for these services are generally billed monthly and the associated fee revenue is
recognized as billed. Collateral management fees are charged to clearing firms that have collateral on deposit with the clearing house to meet their
minimum performance bond and guaranty fund obligations on the exchange. These fees are calculated based on daily collateral balances
12

-- 12 of 38 --

Table of Contents
and are billed monthly. This fee revenue is recognized monthly as billed as the customers receive and consume the benefits of the services. The company
also has an equity membership program which provides equity members the option to pay a monthly subscription fee in satisfaction of their existing
requirement to hold CME Group Class A common stock. Choosing to pay this fee in lieu of holding Class A shares is entirely voluntary and the client's
choice. Fee revenue under this program is earned monthly as billed over the contractual term. Pricing for strategic relationships may be driven by customer
levels and activity. There are fee arrangements which provide for monthly as well as quarterly payments in arrears. Revenue is recognized monthly for
strategic relationship arrangements as the customers receive and consume the benefits of the services.
The following table represents a disaggregation of revenue from contracts with customers by product line for the quarters and six months ended June 30,
2026 and 2025:
Quarter Ended
June 30, Six Months Ended
June 30,
(in millions) 	2026 	2025 	2026 	2025
Interest rates 	$ 	433.0 $ 	461.6 $ 	954.2 $ 	897.9
Equity indexes 	324.0 	301.6 	639.6 	605.8
Foreign exchange 	49.8 	52.4 	106.6 	105.8
Agricultural commodities 	183.8 	174.7 	351.3 	339.0
Energy 	187.0 	217.4 	450.7 	433.8
Metals 	76.7 	85.1 	195.1 	156.0
BrokerTec fixed income 	40.1 	37.1 	80.3 	72.9
EBS foreign exchange 	33.8 	37.5 	70.2 	72.7
Interest rate swap 	24.3 	20.6 	47.1 	41.4
Total clearing and transaction fees 	1,352.5 	1,388.0 	2,895.1 	2,725.3
Market data and information services 	238.1 	198.1 	462.2 	392.6
Other 	115.6 	105.9 	229.0 	216.4
Total revenues 	$ 1,706.2 $ 1,692.0 $ 3,586.3 $ 3,334.3
Timing of Revenue Recognition
Services transferred at a point in time 	$ 1,323.4 $ 1,361.7 $ 2,840.4 $ 2,670.8
Services transferred over time 	377.3 	324.7 	734.6 	652.9
One-time charges and miscellaneous revenues 	5.5 	5.6 	11.3 	10.6
Total revenues 	$ 1,706.2 $ 1,692.0 $ 3,586.3 $ 3,334.3
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, and customer advances and deposits (contract
liabilities) on the consolidated balance sheets. Certain fees for transactions, annual licenses, and other revenue arrangements are billed upfront before
revenue is recognized, which results in the recognition of contract liabilities. These liabilities are recognized on the consolidated balance sheets on a
contract-by-contract basis upon commencement of services under the customer contract. These upfront customer payments are recognized as revenue over
time as the obligations under the contracts are satisfied. Changes in the contract liability balances during the second quarter of 2026 were not materially
impacted by any other factors. The balance of contract liabilities was $52.8 million and $16.7 million as of June 30, 2026 and December 31, 2025,
respectively.
4. Performance Bonds and Guaranty Fund Contributions
Performance Bonds and Guaranty Fund Contribution Reinvestment. CME reinvests cash performance bonds and guaranty fund contributions and
distributes a portion of the interest earned back to the clearing firms. The reinvestment of cash can include certain commercial and central bank deposits,
government securities, reverse repurchase agreements, and money market funds. CME has been designated as a systemically important financial market
utility by the Financial Stability Oversight Council and is authorized to maintain cash accounts at the Federal Reserve Bank of Chicago. At June 30, 2026,
CME maintained $138.5 billion within the cash account at the Federal Reserve Bank of Chicago. The cash deposit at the Federal Reserve Bank of Chicago
is included within performance bonds and guaranty fund contributions on the consolidated balance sheets. Cash performance bonds and guaranty fund
contributions are included as restricted cash and restricted cash equivalents on the consolidated statements of cash flows.
In the second quarter and first six months of 2026, earnings from cash performance bond and guaranty fund contributions were $1,388.8 million and
$2,759.8 million, respectively, compared with $1,487.6 million and $2,361.2 million in the second quarter
13

-- 13 of 38 --

Table of Contents
and first six months of 2025. In the second quarter and first six months of of 2026, expenses related to the distribution of interest earned on collateral
reinvestments were $1,265.7 million and $2,514.9 million, respectively, compared with $1,374.5 million and $2,179.3 million in the second quarter and
first six months of 2025. The earnings from cash performance bonds and guaranty fund contributions are included in investment income and the expense
related to the distribution of interest earned is included in other non-operating income (expense) on the consolidated statements of income.
Clearing House Contract Settlement. The clearing house marks-to-market open positions at least once each business day (twice each business day for all
futures and options contracts). Based on values derived from the mark-to-market process, the clearing house requires payments from clearing firms whose
positions have lost value and makes payments to clearing firms whose positions have gained value. Under the extremely unlikely scenario of simultaneous
default by every clearing firm who has open positions with unrealized losses, the maximum exposure at the time of default related to futures and options on
futures positions would be one half of a business day of changes in fair value of all open positions, before considering the clearing house's ability to access
defaulting clearing firms' collateral deposits. For cleared interest rate swap contracts, the maximum exposure at the time of default related to the clearing
house's guarantee would be one full business day of changes in fair value of all open positions, before considering the clearing house's ability to access
defaulting clearing firms' collateral.
During the first six months of 2026, the clearing house transferred an average of approximately $8.7 billion a day through its clearing systems for
settlement from clearing firms whose positions had lost value to clearing firms whose positions had gained value. The clearing house reduces its guarantee
exposure through initial and maintenance performance bond requirements and mandatory guaranty fund contributions. Management has assessed the fair
value of the company’s settlement guarantee liability by taking the following factors into consideration: the design and operations of the clearing risk
management process, the financial safeguard packages in place, historical evidence of default by a clearing firm and the estimated probability of potential
payouts by the clearing house. Based on the assessment performed, management estimates the guarantee liability to be nominal and therefore has not
recorded any liability at June 30, 2026 and December 31, 2025. The company does not have a history of significant losses recognized on performance bond
collateral as posted by our clearing firms, and management currently does not anticipate any future credit losses on its performance bond assets.
Accordingly, the company has not provided an allowance for credit losses on these performance bond deposits, nor has it recorded any liabilities to reflect
an allowance for credit losses related to our off-balance sheet credit exposures and guarantees.
14

-- 14 of 38 --

Table of Contents
5. Intangible Assets and Goodwill
Intangible assets consisted of the following at June 30, 2026 and December 31, 2025:
June 30, 2026 	December 31, 2025
(in millions) 	Assigned Value
Accumulated
Amortization
Net Book
Value 	Assigned Value
Accumulated
Amortization
Net Book
Value
Amortizable Intangible Assets:
Clearing firm, market data and other customer relationships 	$ 4,695.3 $ 	(2,661.8) $ 	2,033.5 $ 4,703.0 $ (2,557.5) $ 	2,145.5
Technology-related intellectual property 	62.5 	(62.5) 	— 	62.5 	(62.5) 	—
Other 	73.3 	(62.2) 	11.1 	73.9 	(58.7) 	15.2
Total amortizable intangible assets 	$ 4,831.1 $ 	(2,786.5) $ 	2,044.6 $ 4,839.4 $ (2,678.7) $ 	2,160.7
Indefinite-Lived Intangible Assets:
Trade names 	450.0 	450.0
Total intangible assets – other, net 	$ 	2,494.6 	$ 	2,610.7
Trading products 	$ 17,175.3 	$ 17,175.3
(1) Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board
of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which
have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term
limits.
Total amortization expense for intangible assets was $56.0 million and $56.1 million for the quarters ended June 30, 2026 and 2025, respectively. Total
amortization expense for intangible assets was $112.1 million and $111.3 million for the six months ended June 30, 2026 and 2025, respectively. During the
six months ended June 30, 2026, the net book value of amortizable intangible assets included $4.1 million of foreign currency translation for the period.
As of June 30, 2026, the future estimated amortization expense related to amortizable intangible assets is expected to be as follows:
(in millions) 	Amortization Expense
Remainder of 2026 	$ 	111.1
2027 	220.9
2028 	214.4
2029 	214.4
2030 	214.4
2031 	214.4
Thereafter 	855.0
Goodwill activity consisted of the following for the periods ended June 30, 2026 and December 31, 2025:
(in millions) 	Goodwill
Balance at December 31, 2024 	$ 	10,486.9
Foreign currency translation 	27.8
Balance at December 31, 2025 	10,514.7
Foreign currency translation 	(8.9)
Balance at June 30, 2026 	$ 	10,505.8
(1)
15

-- 15 of 38 --

Table of Contents
6. Debt
Long-term debt consisted of the following at June 30, 2026 and December 31, 2025:
(in millions) 	June 30, 2026 	December 31, 2025
$500.0 million fixed rate notes due June 2028, stated rate of 3.75% 	$ 	499.2 $ 	498.9
$750.0 million fixed rate notes due March 2030, stated rate of 4.40% 	743.0 	742.1
$750.0 million fixed rate notes due March 2032, stated rate of 2.65% 	745.0 	744.6
$750.0 million fixed rate notes due September 2043, stated rate of 5.30% 	744.7 	744.6
$700.0 million fixed rate notes due June 2048, stated rate of 4.15% 	692.3 	692.1
Total long-term debt 	$ 	3,424.2 $ 	3,422.3
(1) The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest
payable on the notes effectively became fixed at a rate of 4.73%.
Long-term debt maturities, at par value, were as follows at June 30, 2026:
(in millions) 	Par Value
2027 	$ 	—
2028 	500.0
2029 	—
2030 	750.0
2031 	—
Thereafter 	2,200.0
7. Contingencies
Legal and Regulatory Matters. In the normal course of business, the company discusses matters with its regulators raised during regulatory examinations or
otherwise subject to their inquiry and oversight. These matters could result in censures, fines, penalties or other sanctions. Management believes the
outcome of any resulting actions will not have a material impact on the company's consolidated financial position or results of operations. However, the
company is unable to predict the outcome or the timing of the ultimate resolution of these matters, or the potential fines, penalties or injunctive or other
equitable relief, if any, that may result from these matters.
A putative class action complaint was filed January 15, 2014 in the Circuit Court of Cook County, Chancery Division, against CME Group Inc. and the
Board of Trade of the City of Chicago, Inc. The plaintiffs, certain Class B shareholders of CME Group and Class B members of CBOT, allege breach of
contract and breach of the implied covenant of good faith and fair dealing for violations of their core rights granted in the defendants’ respective
Certificates of Incorporation. On December 2, 2021, the court granted the plaintiffs’ motion for certification of a damages-only class. In early 2024, the
defendants moved for summary judgment on all claims. On April 16, 2025, the court granted the motion in part and denied the motion in part, and set the
remaining claims for a jury trial. After a three week trial, on July 25, 2025, the jury returned a unanimous verdict in favor of the defendants on all counts.
On June 15, 2026, the court denied the plaintiffs' post-trial motions. The plaintiffs have filed a notice of appeal.
In addition, the company is a defendant in, and has potential for, various other legal proceedings arising from its regular business activities. While the
ultimate results of such proceedings against the company cannot be predicted with certainty, the company believes that the resolution of any of these
matters on an individual or aggregate basis will not have a material impact on its consolidated financial position or results of operations. No accrual was
required for contingent legal and regulatory matters as none were probable and estimable as of June 30, 2026 and December 31, 2025.
Intellectual Property Indemnifications. Certain agreements with customers and other third parties related to accessing the CME Group platforms, utilizing
market data services and licensing CME SPAN and SPAN 2 software may contain indemnifications from intellectual property claims that may be made
against them as a result of their use of the applicable products and/or services. The potential future claims relating to these indemnifications cannot be
estimated and therefore no liability has been recorded.
8. Leases
The company has operating leases for corporate offices. The operating leases have remaining lease terms of up to 12 years, some of which include options
to extend or renew the leases for up to an additional five years, and some of which include options to early terminate the leases in less than 12 months.
Management evaluates whether these options are exercisable at least quarterly in order to determine whether the contract term must be reassessed. For a
small number of the leases, primarily
(1)
16

-- 16 of 38 --

Table of Contents
the international locations, management’s approach is to enter into short-term leases for a lease term of 12 months or less in order to provide for greater
flexibility in the local environment. For certain office spaces, the company has entered into arrangements to sublease excess space to third parties, while the
original lease contract remains in effect with the landlord.
The company also has one finance lease, which is related to the sale of our data center in 2016. In connection with the sale, the company leased back a
portion of the property. The transaction was recognized under the financing method and not as a sale leaseback arrangement.
The right-of-use lease asset is recorded within other assets, and the present value of the lease liability is recorded within other liabilities (segregated
between short term and long term) on the consolidated balance sheets. The discount rate applied to the lease payments represents the company’s
incremental borrowing rate.
The components of lease costs were as follows:
Quarter Ended
June 30,
Six Months Ended
June 30,
(in millions) 	2026 	2025 	2026 	2025
Operating lease expense:
Operating lease cost 	$ 	13.6 $ 	4.1 $ 	25.5 $ 	13.8
Short-term lease cost 	0.1 	0.1 	0.2 	0.2
Total operating lease expense included in other expense 	$ 	13.7 $ 	4.2 $ 	25.7 $ 	14.0
Finance lease expense:
Interest expense 	$ 	0.5 $ 	0.5 $ 	0.9 $ 	1.0
Depreciation expense 	2.1 	2.1 	4.3 	4.3
Total finance lease expense 	$ 	2.6 $ 	2.6 $ 	5.2 $ 	5.3
Sublease revenue included in other revenue 	$ 	3.9 $ 	3.3 $ 	7.8 $ 	6.2
Supplemental cash flow information related to leases was as follows:
Quarter Ended
June 30,
Six Months Ended
June 30,
(in millions) 	2026 	2025 	2026 	2025
Cash outflows for operating leases 	$ 	15.8 $ 	15.2 $ 	29.9 $ 	30.3
Cash outflows for finance lease 	4.4 	4.3 	8.8 	8.7
Supplemental balance sheet information related to leases was as follows:
Operating leases
(in millions) 	June 30, 2026 	December 31, 2025
Operating lease right-of-use assets 	$ 	334.8 	$ 	210.3
Operating lease liabilities:
Other current liabilities 	$ 	54.8 	$ 	46.8
Other liabilities 	343.2 	237.4
Total operating lease liabilities 	$ 	398.0 	$ 	284.2
Weighted average remaining lease term (in months) 	104 	99
Weighted average discount rate 	4.4 % 	4.1 %
17

-- 17 of 38 --

Table of Contents
Finance lease
(in millions) 	June 30, 2026 	December 31, 2025
Finance lease right-of-use assets 	$ 	41.2 	$ 	45.5
Finance lease liabilities:
Other current liabilities 	$ 	9.1 	$ 	9.0
Other liabilities 	37.2 	41.7
Total finance lease liabilities 	$ 	46.3 	$ 	50.7
Weighted average remaining lease term (in months) 	57 	63
Weighted average discount rate 	3.5 % 	3.5 %
Future minimum lease payments were as follows as of June 30, 2026 for operating and finance leases:
(in millions) 	Operating Leases
Remainder of 2026 	$ 	36.8
2027 	66.2
2028 	60.8
2029 	50.5
2030 	49.8
2031 	48.2
Thereafter 	163.6
Total lease payments 	475.9
Less: imputed interest 	(77.9)
Present value of lease liability 	$ 	398.0
(in millions) 	Finance Leases
Remainder of 2026 	$ 	8.8
2027 	17.8
2028 	17.9
2029 	18.1
2030 	18.3
2031 	4.6
Thereafter 	—
Total lease payments 	85.5
Less: imputed interest 	(39.2)
Present value of lease liability 	$ 	46.3
9. Guarantees
Mutual Offset Agreement. CME and Singapore Exchange Limited (SGX) maintain a mutual offset agreement with a current term through April 2027. This
agreement enables market participants to open a futures position on one exchange and liquidate it on the other. The term of the agreement will
automatically renew for a two-year period after April 2027 unless either party provides advance notice of their intent to terminate. CME can maintain
collateral in the form of irrevocable, standby letters of credit. At June 30, 2026, CME was contingently liable to SGX on letters of credit totaling $400.0
million. CME also maintains a $350.0 million line of credit to meet its obligations under this agreement. Regardless of the collateral, CME guarantees all
cleared transactions submitted through SGX and would initiate procedures designed to satisfy these financial obligations in the event of a default, such as
the use of performance bonds and guaranty fund contributions of the defaulting clearing firm. Management has assessed the fair value of the company’s
guarantee liability under this mutual offset agreement by taking the following factors into consideration: the design and operations of the clearing risk
management process, the financial safeguard
18

-- 18 of 38 --

Table of Contents
packages in place, historical evidence of default by a clearing firm and the estimated probability of potential payouts by the clearing house. Based on the
assessment performed, management estimates the guarantee liability to be nominal and therefore has not recorded any liability at June 30, 2026 and
December 31, 2025.
Family Farmer and Rancher Protection Fund. In 2012, the company established the Family Farmer and Rancher Protection Fund (the Fund). The Fund is
designed to provide payments, up to certain maximum levels, to family farmers, ranchers and other agricultural industry participants who use the
company’s agricultural commodity products and who suffer losses to their segregated account balances due to their CME clearing firm becoming insolvent.
Under the terms of the Fund, farmers and ranchers are eligible for up to $25,000 per participant. Farming and ranching cooperatives are eligible for up to
$100,000 per cooperative. The Fund was established with a maximum of $100.0 million available for distribution to participants. Since its establishment,
the Fund has made payments of approximately $2.0 million, which leaves $98.0 million available for future claims. If, at any time, payments due to
participants were to exceed the amount remaining in the Fund, payments would be pro-rated. Clearing firms and customers must register with the company
in advance and provide certain documentation in order to substantiate their eligibility. The company believes that its guarantee liability is nominal and
therefore has not recorded any liability at June 30, 2026 and December 31, 2025.
10. Accumulated Other Comprehensive Income (Loss)
The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other
comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss):
(in millions) Investment
Securities
Defined Benefit
Plans
Derivative
Investments
Foreign Currency
Translation 	Total
Balance at December 31, 2025 	$ 	— $ 	0.3 $ 	56.2 $ 	25.4 $ 	81.9
Other comprehensive income (loss) before
reclassifications and income tax benefit (expense) 	(0.1) 	(2.2) 	— 	(26.6) 	(28.9)
Amounts reclassified from accumulated other
comprehensive income (loss) 	— 	(0.1) 	(2.1) 	— 	(2.2)
Income tax benefit (expense) 	— 	0.5 	0.5 	3.1 	4.1
Net current period other comprehensive income (loss) 	(0.1) 	(1.8) 	(1.6) 	(23.5) 	(27.0)
Balance at June 30, 2026 	$ 	(0.1) $ 	(1.5) $ 	54.6 $ 	1.9 $ 	54.9
(in millions) Investment
Securities
Defined Benefit
Plans
Derivative
Investments
Foreign Currency
Translation 	Total
Balance at December 31, 2024 	$ 	(0.3) $ 	(14.1) $ 	59.3 $ 	(150.4) $ 	(105.5)
Other comprehensive income (loss) before
reclassifications and income tax benefit (expense) 	0.1 	(1.2) 	— 	164.3 	163.2
Amounts reclassified from accumulated other
comprehensive income (loss) 	— 	(0.1) 	(2.0) 	— 	(2.1)
Income tax benefit (expense) 	— 	0.3 	0.5 	(11.0) 	(10.2)
Net current period other comprehensive income (loss) 	0.1 	(1.0) 	(1.5) 	153.3 	150.9
Balance at June 30, 2025 	$ 	(0.2) $ 	(15.1) $ 	57.8 $ 	2.9 $ 	45.4
11. Fair Value Measurements
The company uses a three-level classification hierarchy of fair value measurements for disclosure purposes:
• Level 1 inputs, which are considered the most reliable evidence of fair value, consist of quoted prices (unadjusted) for identical assets or liabilities
in active markets.
• Level 2 inputs consist of observable market data, such as quoted prices for similar assets and liabilities in active markets, or inputs other than
quoted prices that are directly observable.
• Level 3 inputs consist of unobservable inputs which are derived and cannot be corroborated by market data or other entity-specific inputs.
19

-- 19 of 38 --

Table of Contents
The company’s level 1 assets generally include investments in publicly traded mutual funds, equity securities and corporate debt securities with quoted
market prices. In general, the company uses quoted prices in active markets for identical assets to determine the fair value of marketable securities.
The company’s level 2 assets and liabilities generally consist of long-term debt notes. The fair values of the long-term debt notes were based on quoted
market prices in an inactive market.
The company’s level 3 assets and liabilities include certain investments that were adjusted to fair value.
Recurring Fair Value Measurements. Financial assets and liabilities recorded at fair value on the consolidated balance sheet as of June 30, 2026 were
classified in their entirety based on the lowest level of input that was significant to each asset and liability’s fair value measurement. The following table
presents financial instruments measured at fair value on a recurring basis:
June 30, 2026
(in millions) 	Level 1 	Level 2 	Level 3 	Total
Assets at Fair Value:
Marketable securities:
Corporate debt securities 	$ 	6.8 $ 	— $ 	— $ 	6.8
Mutual funds 	123.6 	— 	— 	123.6
Equity securities 	1.0 	— 	— 	1.0
Total Marketable Securities 	131.4 	— 	— 	131.4
Total Assets at Fair Value 	$ 	131.4 $ 	— $ 	— $ 	131.4
Non-Recurring Fair Value Measurements. The company recognized impairment charges of $28.9 million related to two of its privately-held equity
investments during the first six months of 2026. The fair value of one of the investments was estimated to be zero at the impairment date and the fair value
of the other investment was estimated to be $1.6 million at the impairment date. The company also recognized unrealized gains on investments of $7.6
million on equity investments without readily determinable fair values during the first six months of 2026. The fair values of these investments were
estimated to be $27.7 million at June 30, 2026. This fair value assessment was based on quantitative factors, including observable price changes. The fair
value measurement of these investments are considered level 3 and non-recurring. These investments are included in other assets on the consolidated
balance sheet.
Fair Values of Debt Notes. The following presents the estimated fair values of long-term debt notes, which are carried at amortized cost on the consolidated
balance sheets. The fair values below are classified as level 2 under the fair value hierarchy and were estimated using quoted market prices in inactive
markets.
At June 30, 2026, the fair values were as follows:
(in millions) 	Fair Value 	Level
$500.0 million fixed rate notes due June 2028 	$ 	495.2 	Level 2
$750.0 million fixed rate notes due March 2030 	748.4 	Level 2
$750.0 million fixed rate notes due March 2032 	677.4 	Level 2
$750.0 million fixed rate notes due September 2043 	749.1 	Level 2
$700.0 million fixed rate notes due June 2048 	584.7 	Level 2
20

-- 20 of 38 --

Table of Contents
12. Earnings Per Share
The company calculates basic earnings per share for the quarter ended June 30, 2026 by dividing net income by the weighted average number of shares of
all classes of common stock outstanding for each reporting period. Diluted earnings per share reflects the increase in shares using the treasury stock method
to reflect the impact of an equivalent number of shares of common stock if restricted stock awards were converted into common stock. The company uses
the two-class method for calculating basic EPS and the if-converted method for diluted EPS for the six months ended June 30, 2026. This reflects the Series
G preferred stock’s status as participating securities until their 1:1 conversion into 4.6 million Class A common shares on March 5, 2026. Under the two-
class method, undistributed or overdistributed earnings are allocated to common stock and participating securities according to their respective rights in
undistributed or overdistributed earnings, as if all the earnings for the period had been distributed. Basic earnings per common share is computed by
dividing the net income attributable to common shareholders by the weighted average number of common shares outstanding during the period. Net
income attributable to common shareholders is reduced for preferred stock dividends earned during the period. Preferred stock also receives a proportionate
allocation of undistributed or overdistributed earnings for the period because the shares of the Series G preferred stock have a contractual obligation to
share in profits and losses of the company. Diluted earnings per share is computed using the if-converted method for the Series G preferred stock which
assumes the conversion of all preferred shares into common shares at the beginning of the period. Accordingly, net income attributable to common
shareholders is adjusted to add back the dividends and undistributed or overdistributed earnings previously allocated to the preferred stock, and the
weighted average number of common shares outstanding is increased by the number of shares that would have been issued upon conversion of the
preferred stock as of the beginning of the period plus potentially dilutive common shares. Anti-dilutive stock awards were as follows for the periods
presented:
Quarter Ended
June 30,
Six Months Ended
June 30,
(in thousands) 	2026 	2025 	2026 	2025
Stock awards 	34 	— 	34 	47
Total 	34 	— 	34 	47
The following table presents the earnings per share calculation for the periods presented:
Quarter Ended
June 30,
Six Months Ended
June 30,
2026 	2025 	2026 	2025
Net Income (in millions) 	$ 	1,041.8 $ 	1,025.1 $ 	2,196.1 $ 	1,981.3
Less: preferred stock dividends 	— 	(5.7) 	— 	(11.5)
Add: overdistributed earnings allocated to preferred stock 	— 	— 	4.3 	—
Less: undistributed earnings allocated to preferred stock 	— 	(7.2) 	— 	(13.4)
Net Income Attributable to Common Shareholders of CME Group - Basic 	$ 	1,041.8 $ 	1,012.2 $ 	2,200.4 $ 	1,956.4
Less: overdistributed earnings allocated to preferred stock 	— 	— 	(4.3) 	—
Net Income Attributable to Common Shareholders of CME Group - Diluted 	$ 	1,041.8 $ 	1,012.2 $ 	2,196.1 $ 	1,956.4
Weighted Average Number of Common Shares (in thousands):
Basic 	360,684 	359,658 	360,005 	359,636
Effect of restricted stock and performance shares 	598 	697 	632 	661
Effect of convertible preferred shares 	— 	— 	1,596 	—
Diluted 	361,282 	360,355 	362,233 	360,297
Earnings per Common Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.89 $ 	2.81 $ 	6.11 $ 	5.44
Diluted 	2.88 	2.81 	6.06 	5.43
21

-- 21 of 38 --

Table of Contents
13. Segment Reporting
The company's business is conducted through one reportable business segment, CME Group consolidated. The company has one operating segment as this
is the level at which resource allocation and operating decisions regarding company performance are evaluated and determined by the senior leadership
team.
The chief operating decision maker (CODM) reviews the financial results of CME Group consolidated on an ongoing basis throughout the year. As a single
segment, the segment profitability measure is consolidated net income. Consolidated net income informs key operating decisions as made by the CODM,
which include bonus allocation, discretionary share-based awards, liquidity and cash needs, new product development, existing product expansion and
product discontinuation. Consolidated net income is deemed the best indicator of segment performance. Segment assets are not reported to, or used by, the
CODM to allocate resources or to assess performance.
The CODM evaluates current period consolidated net income performance as compared to prior periods, budgeted results and forecasts. The CODM
reviews consolidated revenues as disaggregated by the following: clearing and transaction fees as a combination of rate per contract and average daily
volume for each major asset class, market data fee revenue and other revenue. The significant expense categories are consistent with those presented on the
face of the consolidated statements of income. The components of non-operating income are also reviewed by the CODM. It is noted that the level of
financial information provided to the CODM is consistent with the financial statement line items as disclosed in our consolidated statements of income.
14. Subsequent Events
The company has evaluated subsequent events through the date the financial statements were issued. The company has determined that there were no
subsequent events that met the requirement for recognition or disclosure in the consolidated financial statements.
22

-- 22 of 38 --

Table of Contents
ITEM 2. 	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion is provided as a supplement to, and should be read in conjunction with, the accompanying unaudited consolidated financial
statements and notes in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the
SEC on February 26, 2026.
References in this discussion and analysis to “we” and “our” are to CME Group Inc. (CME Group) and its consolidated subsidiaries, collectively.
References to “exchange” are to Chicago Mercantile Exchange Inc. (CME), the Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile
Exchange, Inc. (NYMEX), and Commodity Exchange, Inc. (COMEX), collectively, unless otherwise noted.
RESULTS OF OPERATIONS
Financial Highlights
The following summarizes significant changes in our financial performance for the periods presented.
Quarter Ended
June 30,
Six Months Ended
June 30,
(dollars in millions, except per share data) 	2026 	2025 	Change 	2026 	2025 	Change
Total revenues 	$ 	1,706.2 	$ 	1,692.0 	1 % $ 	3,586.3 	$ 	3,334.3 	8 %
Total expenses 	599.1 	562.7 	6 	1,169.5 	1,097.0 	7
Operating margin 	64.9 % 	66.7 % 	67.4 % 	67.1 %
Non-operating income (expense) 	$ 	220.6 	$ 	201.0 	10 	$ 	421.8 	$ 	337.8 	25
Effective tax rate 	21.5 % 	22.9 % 	22.6 % 	23.1 %
Net income 	$ 	1,041.8 	$ 	1,025.1 	2 	$ 	2,196.1 	$ 	1,981.3 	11
Diluted earnings per common share 	2.88 	2.81 	2 	6.06 	5.43 	12
Cash flows from operating activities 	2,207.0 	2,175.1 	1
Revenues
Quarter Ended
June 30, Six Months Ended
June 30,
(dollars in millions) 	2026 	2025 	Change 	2026 	2025 	Change
Clearing and transaction fees 	$ 	1,352.5 $ 	1,388.0 	(3)% $ 	2,895.1 $ 	2,725.3 	6 %
Market data and information services 	238.1 	198.1 	20 	462.2 	392.6 	18
Other 	115.6 	105.9 	9 	229.0 	216.4 	6
Total Revenues 	$ 	1,706.2 $ 	1,692.0 	1 	$ 	3,586.3 $ 	3,334.3 	8
Clearing and Transaction Fees
Futures and Options Contracts
The following table summarizes our total contract volume, revenue and average rate per contract for futures and options. Total contract volume includes
contracts that are traded on our exchange and cleared through our clearing house and certain cleared-only contracts. Volume is measured in round turns,
which is considered a completed transaction that involves a purchase and an offsetting sale of a contract. Average rate per contract is determined by
dividing total clearing and transaction fees by total contract volume. Contract volume and average rate per contract disclosures below exclude trading
volume for event contracts, the cash markets business as well as interest rate swaps.
Quarter Ended
June 30,
Six Months Ended
June 30,
2026 	2025 	Change 	2026 	2025 	Change
Total contract volume (in millions) 	1,850.2 	1,873.4 	(1)% 	4,060.3 	3,689.3 	10 %
Clearing and transaction fees (in millions) 	$ 	1,254.3 $ 	1,292.8 	(3) 	$ 	2,697.5 $ 	2,538.3 	6
Average rate per contract 	$ 	0.678 $ 	0.690 	(2) 	$ 	0.664 $ 	0.688 	(3)
23

-- 23 of 38 --

Table of Contents
We estimate the following net changes in clearing and transaction fees based on the changes in total contract volumes and the changes in average rate per
contract for futures and options during the second quarter and first six months of 2026 when compared with the same periods in 2025.
(in millions) 	Quarter Ended Six Months
Ended
Increase (decrease) due to change in total contract volume 	$ 	(15.8) $ 	246.5
Decreases due to change in average rate per contract 	(22.7) 	(87.3)
Net increase (decrease) in clearing and transaction fees 	$ 	(38.5) $ 	159.2
Average rate per contract is impacted by our rate structure, including volume-based incentives; product mix; trading venue; and the percentage of volume
executed by customers who are members compared with non-member customers. Due to the relationship between average rate per contract and contract
volume, the change in clearing and transaction fees attributable to changes in each is only an approximation.
Contract Volume
The following table summarizes average daily contract volume. Contract volume can be influenced by many factors, including political and economic
conditions, the regulatory environment and market competition.
Quarter Ended
June 30, Six Months Ended
June 30,
(amounts in thousands) 	2026 	2025 	Change 	2026 	2025 	Change
Average Daily Volume by Product Line:
Interest rates 	14,532 	15,472 	(6)% 	16,586 	15,252 	9 %
Equity indexes 	8,634 	7,661 	13 	8,644 	7,827 	10
Foreign exchange 	989 	1,096 	(10) 	1,091 	1,123 	(3)
Energy 	2,667 	3,082 	(13) 	3,320 	2,993 	11
Agricultural commodities 	2,080 	1,964 	6 	2,061 	1,961 	5
Metals 	941 	942 	— 	1,309 	838 	56
Aggregate average daily volume 	29,843 	30,217 	(1) 	33,011 	29,994 	10
Average Daily Volume by Venue:
CME Globex 	27,935 	28,097 	(1) 	30,761 	27,916 	10
Open outcry 	830 	993 	(16) 	1,034 	938 	10
Privately negotiated 	1,078 	1,127 	(4) 	1,216 	1,140 	7
Aggregate average daily volume 	29,843 	30,217 	(1) 	33,011 	29,994 	10
Electronic Volume as a Percentage of Total Volume 	94 % 	93 % 	93 % 	93 %
Overall market volatility was high in early 2026 due to the heightened geopolitical conflict in the Middle East, which has caused a ripple effect throughout
the world economy. In addition, uncertainty remained high within the energy and metals markets as the Middle East conflict caused significant supply
disruptions and led market participants to turn to precious metals amid this uncertainty. However, in the second quarter of 2026, overall market volatility
subsided relative to periods of very high volatility earlier in the year as market uncertainty tapered. We believe these factors contributed to volume
remaining relatively flat in the second quarter of 2026 when compared to the same period in 2025 and an increase in volume in the first six months of 2026
when compared with the same period in 2025.
24

-- 24 of 38 --

Table of Contents
Interest Rate Products
The following table summarizes average daily contract volume for our key interest rate products.
Quarter Ended
June 30,
Six Months Ended
June 30,
(amounts in thousands) 	2026 	2025 	Change 	2026 	2025 	Change
SOFR futures and options:
Futures expiring within two years 	3,009 	3,357 	(10)% 	3,501 	3,145 	11 %
Options 	1,212 	1,464 	(17) 	1,611 	1,403 	15
Futures expiring beyond two years 	1,018 	1,226 	(17) 	1,231 	1,189 	4
U.S. Treasury futures and options:
10-Year 	3,532 	3,392 	4 	3,869 	3,580 	8
5-Year 	2,078 	2,287 	(9) 	2,320 	2,241 	4
2-Year 	1,292 	1,180 	10 	1,419 	1,161 	22
Treasury Bond 	717 	839 	(15) 	814 	821 	(1)
Ultra T-Note 	769 	773 	(1) 	831 	795 	4
Ultra T-Bond 	483 	463 	4 	496 	450 	10
Federal Funds futures and options 	380 	443 	(14) 	452 	422 	7
In the second quarter of 2026, interest rate contract volume was lower compared with the same period in 2025 due to a decrease in market volatility. We
believe this was due to more certainty surrounding the Federal Reserve's future interest rate policy decisions.
Overall interest rate contract volume increased in the first six months of 2026 when compared with same period in 2025 due to periods of high market
volatility. We believe this was due to the heightened geopolitical conflict in the Middle East, which led to initial uncertainty surrounding the Federal
Reserve's future interest rate policy decisions.
Equity Index and Cryptocurrency Products
The following table summarizes average daily contract volume for our key equity index and cryptocurrency products.
Quarter Ended
June 30,
Six Months Ended
June 30,
(amounts in thousands) 	2026 	2025 	Change 	2026 	2025 	Change
E-mini S&P 500 futures and options 	4,420 	4,349 	2 % 	4,546 	4,435 	3 %
E-mini Nasdaq 100 futures and options 	3,191 	2,415 	32 	2,994 	2,503 	20
E-mini Russell 2000 futures and options 	350 	330 	6 	375 	315 	19
E-mini Dow futures and options 	262 	252 	4 	285 	256 	11
Bitcoin futures and options 	116 	86 	35 	142 	95 	50
Ether futures and options 	89 	102 	(12) 	106 	98 	8
Equity index contract volumes increased in the second quarter and first six months of 2026 when compared with the same periods in 2025. We believe
these increases were due to the geopolitical conflict in the Middle East in early 2026, which caused significant uncertainty throughout the equity markets.
In addition, market shifts in the Nasdaq-100 and Russell 2000 resulted in additional volume within both complexes.
Our cryptocurrency contract volumes increased in the second quarter and first six months of 2026 when compared with the same periods in 2025. We
believe the increased volatility resulted in a broader cryptocurrency market repricing.
25

-- 25 of 38 --

Table of Contents
Foreign Exchange Products
The following table summarizes average daily contract volume for our key foreign exchange products.
Quarter Ended
June 30,
Six Months Ended
June 30,
(amounts in thousands) 	2026 	2025 	Change 	2026 	2025 	Change
Euro 	245 	281 	(13)% 	268 	291 	(8)%
Japanese Yen 	185 	213 	(13) 	197 	210 	(6)
Australian dollar 	122 	119 	3 	143 	116 	23
British Pound 	107 	111 	(4) 	120 	119 	1
Canadian dollar 	87 	92 	(5) 	91 	112 	(18)
In the second quarter and first six months of 2026, overall foreign exchange volumes decreased when compared with the same periods in 2025. Overall
market volatility subsided in the second quarter of 2026 following periods of very high volatility in 2025 due to uncertainty surrounding the United State's
position on tariffs. However, the geopolitical conflict in the Middle East in early 2026 led to higher Australian dollar contract volumes due to uncertainty in
the commodities and energy markets. We believe these factors contributed to lower overall foreign exchange contract volume in the second quarter and first
six months of 2026 when compared with the same periods in 2025.
Energy Products
The following table summarizes average daily contract volume for our key energy products.
Quarter Ended
June 30, Six Months Ended
June 30,
(amounts in thousands) 	2026 	2025 	Change 	2026 	2025 	Change
WTI crude oil 	1,465 	1,517 	(3)% 	1,763 	1,372 	29 %
Natural gas 	658 	871 	(24) 	868 	970 	(11)
Refined products 	341 	437 	(22) 	428 	431 	(1)
Brent crude oil 	186 	232 	(20) 	243 	195 	25
Energy contract volumes decreased in the second quarter of 2026 when compared with the same period in 2025, which we believe was due to lower overall
volatility. Despite the ongoing geopolitical conflict in the Middle East, tensions eased within the region leading to broader price stabilization during the
second quarter.
The geopolitical conflict in the Middle East in early 2026 disrupted crucial supply chain routes and created higher uncertainty within the crude oil markets.
We believe this contributed to higher crude oil volume in the first six months of 2026 when compared with the same period in 2025.
Agricultural Commodity Products
The following table summarizes average daily contract volume for our key agricultural commodity products.
Quarter Ended
June 30, Six Months Ended
June 30,
(amounts in thousands) 	2026 	2025 	Change 	2026 	2025 	Change
Corn 	673 	591 	14 % 	631 	630 	— %
Soybean 	351 	391 	(10) 	384 	387 	(1)
Wheat 	326 	267 	22 	312 	266 	17
Overall commodity contract volumes increased in the second quarter and first six months of 2026 when compared with the same periods in 2025. The
heightened geopolitical conflict in the Middle East in early 2026 caused disruptions within the grain market supply routes. The conflict also caused a
greater demand for crop-based fuels as a result of crude oil pricing uncertainties. We believe these factors contributed to higher overall commodity volume
in the second quarter and first six months of 2026 compared with the same periods in 2025.
26

-- 26 of 38 --

Table of Contents
Metal Products
The following table summarizes average daily volume for our key metal products.
Quarter Ended
June 30,
Six Months Ended
June 30,
(amounts in thousands) 	2026 	2025 	Change 	2026 	2025 	Change
Gold 	639 	667 	(4)% 	865 	569 	52 %
Silver 	167 	117 	43 	285 	109 	160
Copper 	100 	99 	1 	115 	105 	9
Overall metals contract volumes increased during the second quarter and first six months of 2026, when compared to the same periods in 2025, driven
primarily by heightened market volatility. Precious metals volume growth was largely driven by geopolitical tensions in the Middle East early in 2026,
which drove market participants to gold and silver. While the demand subsequently eased within the gold market, sustained volume growth was further
supported by increased adoption of precious metals micro contracts among our retail client base.
Average Rate per Contract
The average rate per contract decreased in the second quarter and first six months of 2026 when compared with the same periods in 2025. The decrease was
largely due to an increase in micro contract volume, specifically within equities, energy and metals, as well as higher member trading as a percentage of
total volume. In the first six months of 2026, the decrease was partially offset by a change in product mix. Energy and metal contract volume increased by 1
percentage point as a percent of total volume, while other products collectively decreased by 1 percentage point. In general, energy and metals products
have a higher rate per contract compared with the remaining contracts. In addition, the overall decrease in the second quarter of 2026 was partially offset by
an increase in certain clearing and transaction fees which went into effect on April 1, 2026.
Cash Markets Business
Total clearing and transaction fees revenues in the second quarter and first six months of 2026 include $73.9 million and $150.5 million, respectively, of
transaction fees attributable to the cash markets business, compared with $74.6 million and $145.6 million, respectively, in the second quarter and first six
months of 2025. This revenue includes BrokerTec Americas LLC's fixed income volume and EBS's foreign exchange volume.
Quarter Ended
June 30,
Six Months Ended
June 30,
(amounts in millions) 	2026 	2025 	Change 	2026 	2025 	Change
BrokerTec fixed income transaction fees 	$ 	40.1 $ 	37.1 	8 % $ 	80.3 $ 	72.9 	10 %
EBS foreign exchange transaction fees 	33.8 	37.5 	(10) 	70.2 	72.7 	(3)
The related average daily notional value for the first quarter of 2026 and 2025 were as follows:
Quarter Ended
June 30,
Six Months Ended
June 30,
(amounts in billions) 	2026 	2025 	Change 	2026 	2025 	Change
U.S. Repo 	$ 	397.3 $ 	362.9 	9 % $ 	395.2 $ 	347.3 	14 %
European Repo (in euros) 	364.0 	310.9 	17 	366.1 	318.4 	15
U.S. Treasury 	91.4 	114.1 	(20) 	99.6 	112.9 	(12)
Spot FX 	67.2 	73.7 	(9) 	71.9 	72.3 	(1)
Overall average daily notional values for the cash markets business were higher in the second quarter and first six months of 2026 when compared with the
same periods in 2025 due to higher overall volatility. We believe this was due to the heightened geopolitical conflict in the Middle East, which caused
significant macro-economic uncertainty throughout the global economy. However, more certainty surrounding the Federal Reserves interest rate policy
decision led to lower overall U.S. Treasury volumes in second quarter and first six months of 2026 when compared with the same periods in 2025. We
believe these factors led to higher overall cash market volume in the second quarter and first six months of 2026 compared with the same periods in 2025.
27

-- 27 of 38 --

Table of Contents
Concentration of Revenue
We bill a substantial portion of our clearing and transaction fees directly to our clearing firms. The majority of clearing and transaction fees received from
clearing firms represent charges for trades executed and cleared on behalf of their customers. One individual firm represented at least 10% of our clearing
and transaction fees in the first six months of 2026. Should a clearing firm withdraw, we believe that the customer portion of the firm’s trading activity
would likely transfer to another clearing firm of the exchange. Therefore, we do not believe we are exposed to significant risk from the ongoing loss of
revenue received from or through a particular clearing firm.
Other Sources of Revenue
Market data and information services. During the second quarter and first six months of 2026, overall market data and information services revenues
increased when compared with the same periods in 2025, largely due to higher usage of certain products, increased demand by new customer segments, and
price increases for certain products.
The two largest resellers of our market data represented approximately 25% of our market data and information services revenue in the first six months of
2026. Despite this concentration, we consider exposure to significant risk of revenue loss to be minimal. In the event that one of these vendors no longer
subscribes to our market data, we believe the majority of that vendor’s customers would likely subscribe to our market data through another reseller.
Additionally, several of our largest institutional customers that utilize services from our two largest resellers report usage and remit payment of their fees
directly to us.
Expenses
Quarter Ended
June 30,
Six Months Ended
June 30,
(dollars in millions) 	2026 	2025 	Change 	2026 	2025 	Change
Compensation and benefits 	$ 	233.5 $ 	221.6 	5 % $ 	456.5 $ 	428.3 	7 %
Technology 	83.3 	70.9 	18 	159.9 	136.6 	17
Professional fees and outside services 	29.1 	37.4 	(22) 	57.3 	65.9 	(13)
Amortization of purchased intangibles 	56.0 	56.1 	— 	112.1 	111.3 	1
Depreciation and amortization 	28.2 	27.3 	3 	55.4 	54.6 	2
Licensing and other fee agreements 	109.1 	96.2 	13 	215.9 	192.8 	12
Other 	59.9 	53.2 	12 	112.4 	107.5 	4
Total Expenses 	$ 	599.1 $ 	562.7 	6 	$ 	1,169.5 $ 	1,097.0 	7
Operating expenses increased by $36.4 million and $72.5 million in the second quarter and first six months of 2026 when compared with the same periods
in 2025. The following table shows the estimated impacts of key factors resulting in the changes in operating expenses:
Quarter Ended
June 30, 2026
Six Months Ended
June 30,
Amount of
Change
Change as a
Percentage of
Total Expenses Amount of
Change
Change as a
Percentage of
Total Expenses	(dollars in millions)
License fees 	$ 	12.9 	2 % $ 	23.1 	2 %
Technology support services 	11.6 	2 	21.1 	2
Rent expense 	9.4 	2 	11.9 	1
Salaries, benefits and employer taxes 	(0.3) 	— 	10.0 	1
Non-qualified deferred compensation 	4.7 	1 	6.2 	1
Marketing expenses 	2.4 	— 	5.0 	1
Stock-based compensation 	4.1 	1 	4.7 	1
Currency fluctuation 	(3.3) 	(1) 	(6.4) 	(1)
Legal fees 	(6.2) 	(1) 	(7.4) 	(1)
Other expenses, net 	1.1 	— 	4.3 	—
Total increase 	$ 	36.4 	6 % $ 	72.5 	7 %
28

-- 28 of 38 --

Table of Contents
Increases in operating expenses in the second quarter and first six months of 2026 when compared with the same periods in 2025 were as follows:
• License fees expenses were higher primarily due to record volumes for certain equity products.
• The increases in technology support services expense were primarily driven by higher third party services to support the ongoing Google Cloud
transformation project.
• Rent expenses were higher primarily due to gains on lease contractions recognized in the first six months of 2025.
• Salaries, benefits and employer taxes expenses were higher in the first six months of 2026 as a result of salary increases that went into effect
during the first quarter of 2026 as well as an increase in headcount, which was primarily attributable to additional headcount in the company's
international locations.
• An increase in our non-qualified deferred compensation liability during the first quarter of 2026, the impact of which does not affect net income
because of an equal and offsetting change in investment income, contributed to the increases in compensation and benefits expenses.
• Marketing expense increased as a result of higher sponsorship, media campaigns and event costs in the first six months of 2026.
• Stock-based compensation expenses increased due to higher expense related to performance awards compared to the same period in 2025.
Decreases in operating expenses in the second quarter and first six months of 2026 when compared with the same periods in 2025 were as follows:
• In the second quarter and first six months of 2026, we recognized a net loss of $0.3 million and a net gain of $0.5 million, respectively, compared
with a net losses of $3.6 million and $5.9 million, respectively, during the same periods in 2025, due to currency exchange rate fluctuations. Gains
and losses from exchange rate fluctuations are recognized in the consolidated statements of net income when subsidiaries with a U.S. dollar
functional currency hold certain monetary assets and liabilities denominated in foreign currencies.
• Legal fees decreased primarily as a result of expenses incurred for the class action lawsuit litigation in the second quarter of 2025.
Non-Operating Income (Expense)
Quarter Ended
June 30,
Six Months Ended
June 30,
(dollars in millions) 	2026 	2025 	Change 	2026 	2025 	Change
Investment income 	$ 	1,429.7 $ 	1,518.4 	(6)% $ 	2,819.0 $ 	2,411.1 	17 %
Interest and other borrowing costs 	(43.6) 	(44.0) 	(1) 	(87.2) 	(85.7) 	2
Equity in net earnings of unconsolidated subsidiaries 	97.7 	99.0 	(1) 	200.1 	187.2 	7
Other non-operating income (expense) 	(1,263.2) 	(1,372.4) 	(8) 	(2,510.1) 	(2,174.8) 	15
Total Non-Operating 	$ 	220.6 $ 	201.0 	10 	$ 	421.8 $ 	337.8 	25
Investment income. Earnings from cash performance bond and guaranty fund contributions that are reinvested decreased in the second quarter of 2026
when compared with the same period in 2025. This was mainly due to a lower average rate of return despite higher overall reinvestment balances. In the
second quarter 2026, earnings from cash performance bond and guaranty fund contributions were $1,388.8 million compared with $1,487.6 million in the
second quarter of 2025.
Earnings from cash performance bond and guaranty fund contributions that are reinvested increased in the first six months of 2026 when compared with the
same period in 2025. This was mainly due to higher reinvestment balances despite a lower average rate of return on the reinvestment balances. In the first
six months of 2026, earnings from cash performance bond and guaranty fund contributions were $2,759.8 million compared with $2,361.2 million in first
six months of 2025. The increase was partially offset by higher net unrealized losses in the first six months of 2026.
Equity in net earnings (losses) of unconsolidated subsidiaries. Higher income generated from our S&P Dow Jones Indices LLC business venture
contributed to an increase in equity in net earnings (losses) of unconsolidated subsidiaries in the first six months of 2026 when compared with 2025.
However, in the second quarter of 2026, equity in net earnings (losses) of unconsolidated subsidiaries was lower as a result of the sale of our OSTTRA
joint venture which occurred in the fourth quarter of 2025.
29

-- 29 of 38 --

Table of Contents
Other non-operating income (expense). We recognized lower expense related to the distribution of interest earned on performance bond collateral
reinvestments to the clearing firms during the second quarter of 2026 when compared with the same period in 2025. This was due to lower interest income
earned on our reinvestment balances as a result of a lower Federal Funds rate compared with the same period in 2025. In the second quarter of 2026,
expense related to the distribution of interest earned on collateral reinvestments was $1,265.7 million compared with $1,374.5 million the second quarter of
2025.
We recognized higher expense related to the distribution of interest earned on performance bond collateral reinvestments to the clearing firms during the
first six months of 2026 when compared with the same period in 2025, mainly due to higher overall cash collateral balances. In the first six months of
2026, expense related to the distribution of interest earned on collateral reinvestments was $2,514.9 million, compared with $2,179.3 million in the first six
months of 2025.
Income Tax Provision
The following table summarizes the effective tax rates for the periods presented:
2026 	2025
Quarter ended June 30 	21.5 % 	22.9 %
Six months ended June 30 	22.6 	23.1
In the second quarter of 2026, the overall effective tax rate decreased when compared with the same period in 2025 as a result of favorable settlements
from state tax examinations. In the first six months of 2026, the overall effective tax rate remained relatively consistent when compared with the same
period in 2025.
Liquidity and Capital Resources
Sources and Uses of Cash. Net cash provided by operating activities increased in the first six months of 2026 when compared with the same period in 2025,
which was largely due to an increase in trading volume and higher interest earned on reinvestment of collateral, net of distributions. Cash used in investing
activities remained relatively consistent in the first six months of 2026 when compared with the same period in 2025. Cash used in financing activities was
higher during the first six months of 2026 when compared with the same period in 2025 due to an increase in share repurchases.
Debt Instruments. The following table summarizes our debt outstanding at June 30, 2026:
(in millions) 	Par Value
Fixed rate notes due June 2028, stated rate of 3.75% 	$ 	500.0
Fixed rate notes due March 2030, stated rate of 4.40% 	750.0
Fixed rate notes due March 2032, stated rate of 2.65% 	750.0
Fixed rate notes due September 2043, stated rate of 5.30% 	750.0
Fixed rate notes due June 2048, stated rate of 4.15% 	700.0
_______________
(1) We maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest
payable effectively became fixed at a rate of 4.73%.
We maintain a $2.3 billion multi-currency revolving senior credit facility with various financial institutions, which matures in April 2030. The proceeds
from this facility can be used for general corporate purposes, which includes providing liquidity for our clearing house in certain circumstances at CME
Group's discretion and, if necessary, for maturities of commercial paper. As long as we are not in default under this facility, we have the option to increase
it up to $3.3 billion with the consent of the agent and lenders providing the additional funds. This facility is voluntarily pre-payable from time to time
without premium or penalty. Under this facility, we are required to remain in compliance with a consolidated net worth test, which is defined as our
consolidated shareholders' equity at December 31, 2024, giving effect to share repurchases made and special dividends paid during the term of the
agreement (and in no event greater than $2.0 billion in aggregate), multiplied by 0.65. We currently do not have any borrowings outstanding under this
facility, but any commercial paper balance if or when outstanding can be backstopped against this facility.
We maintain a 364-day multi-currency revolving secured credit facility with a consortium of domestic and international banks to be used in certain
situations by the clearing house. The facility provides for borrowings of up to $7.0 billion. We may use the proceeds to provide temporary liquidity in the
unlikely event a clearing firm fails to promptly discharge an obligation to the clearing house operated by CME, in the event of a liquidity constraint or
default by a depositary (custodian for our collateral), in the event of a temporary disruption with the domestic payments system that would delay payment
of settlement variation between us and our clearing firms, or in other cases as provided by the CME rulebook. Clearing firm guaranty fund contributions
received in the form of cash or U.S. Treasury securities as well as the performance bond assets (pursuant to the CME rulebook) can be used to collateralize
the facility. At June 30, 2026, guaranty fund contributions available to collateralize
(1)
30

-- 30 of 38 --

Table of Contents
the facility totaled $10.3 billion. We have the option to increase the line from $7.0 billion to $10.0 billion with the consent of the agent and lenders
providing the additional funds. Our 364-day facility contains a requirement that CME remain in compliance with a consolidated tangible net worth test,
defined as CME's consolidated shareholder's equity less intangible assets (as defined in the agreement), of not less than $800.0 million. We currently do not
have any borrowings outstanding under this facility.
The indentures governing our fixed rate notes, our $2.3 billion multi-currency revolving senior credit facility and our 364-day multi-currency revolving
secured credit facility for $7.0 billion do not contain specific covenants that restrict the ability to pay dividends. These documents, however, do contain
other customary financial and operating covenants that place restrictions on the operations of the company that could indirectly affect the ability to pay
dividends.
At June 30, 2026, we have excess borrowing capacity for general corporate purposes of approximately $2.3 billion under our multi-currency revolving
senior credit facility.
We maintain committed repurchase facility agreements amounting to a total of $1.0 billion. The committed repurchase facilities provide access to cash,
secured by non-cash collateral, in the event that one or more of our clearing firms fails to promptly discharge an obligation to the clearing house. The
facilities are subject to annual renewal. We currently do not have any borrowings outstanding under these facilities.
We maintain a committed facility of up to $750.0 million for foreign currency conversions. The committed foreign currency facility allows the clearing
house to convert cash to another currency within generally accepted local market timeframes in the event that one or more of our clearing firms fails to
promptly discharge an obligation to the clearing house. The facility is subject to annual renewal. We currently do not have any foreign currency trades
outstanding under this facility.
At June 30, 2026, we were in compliance with the various covenant requirements of all our debt facilities.
CME Group, as a holding company, has no operations of its own. Instead, it relies on dividends declared and paid to it by its subsidiaries in order to provide
the funds which it uses to pay dividends to its shareholders.
To satisfy our performance bond obligation with Singapore Exchange Limited, we may pledge irrevocable standby letters of credit. At June 30, 2026, the
letters of credit totaled $400.0 million. We also maintain a $350.0 million line of credit to meet our obligations under this agreement.
The following table summarizes our credit ratings at June 30, 2026:
Short-Term 	Long-Term
Rating Agency 	Debt Rating 	Debt Rating 	Outlook
Standard & Poor’s Global Ratings 	A1+ 	AA- 	Stable
Moody’s Investors Service, Inc. 	P1 	Aa3 	Stable
Given our cash flow generation, our ability to pay down debt levels and our ability to refinance existing debt facilities if necessary, we expect to maintain
an investment grade rating. If our ratings are downgraded below investment grade within certain specified time periods due to a change of control, we are
required to make an offer to repurchase our fixed rate notes at a price equal to 101% of the principal amount, plus accrued and unpaid interest. No report of
any rating agency is incorporated by reference herein.
Liquidity and Cash Management. Cash and cash equivalents, excluding restricted cash and restricted cash equivalents, totaled $2.1 billion and $4.4 billion
at June 30, 2026 and December 31, 2025, respectively. The balance retained in cash and cash equivalents is a function of anticipated or possible short-term
cash needs, prevailing interest rates, our corporate investment policy and alternative investment choices. A majority of our cash and cash equivalents
balance is invested in money market mutual funds that invest only in U.S. Treasury securities, U.S. government agency securities and U.S. Treasury
security reverse repurchase agreements and short-term bank deposits. Our exposure to credit and liquidity risk is minimal given the nature of the
investments. Cash that is not available for general corporate purposes because of regulatory requirements or other restrictions is classified as restricted cash
and is included in cash performance bonds and guaranty fund contributions, other current assets or other assets in the consolidated balance sheets. Cash
performance bonds and guarantee fund contribution assets are deemed to be restricted cash and restricted cash equivalents.
We maintain a share repurchase program under which we are authorized to repurchase up to $3.0 billion of our outstanding Class A common stock, par
value $0.01 per share (the common stock), from time to time through open market transactions, block trades, privately negotiated purchase transactions or
other purchase techniques and may include purchases effected pursuant to one or more trading plans established pursuant to Rule 10b5-1 under the
Exchange Act. The timing of any repurchases and the number of shares repurchased under the share repurchase program are within our discretion and may
be affected by various factors, including general market and economic conditions; the market price of the common stock; CME Group’s earnings, financial
condition, capital requirements and levels of indebtedness; legal requirements; and other
31

-- 31 of 38 --

Table of Contents
considerations. The share repurchase program has no expiration date, does not obligate us to acquire any particular amount of common stock and may be
modified, suspended or terminated at any time. As of June 30, 2026, the maximum remaining value of shares to be repurchased was $1.5 billion.
Regulatory Requirements. CME is regulated by the CFTC as a Derivatives Clearing Organization (DCO). DCOs are required to maintain capital, as defined
by the CFTC, in an amount at least equal to one year of projected operating expenses as well as cash, liquid securities, or a line of credit at least equal to six
months of projected operating expenses. CME was designated by the Financial Stability Oversight Council as a systemically important financial market
utility under Title VIII of the Dodd-Frank Wall Street Reform and Consumer Protection Act. As a result, CME must comply with CFTC regulations
applicable to a systemically important DCO for financial resources and liquidity resources. CME is in compliance with all DCO financial requirements.
CME, CBOT, NYMEX and COMEX are regulated by the CFTC as Designated Contract Markets (DCM). DCMs are required to maintain capital, as
defined by the CFTC, in an amount at least equal to one year of projected operating expenses as well as cash, liquid securities or a line of credit at least
equal to six months of projected operating expenses. Our DCMs are in compliance with all DCM financial requirements.
BrokerTec Americas LLC is required to maintain sufficient net capital under Securities Exchange Act of 1934, as amended (Exchange Act), Rule 15c3-1
(the Net Capital Rule). The Net Capital Rule focuses on liquidity and is designed to protect securities customers, counterparties, and creditors by requiring
that broker-dealers have sufficient liquid resources on hand at all times to satisfy claims promptly. Rule 15c3-3, or the customer protection rule, which
complements Rule 15c3-1, is designed to ensure that customer property (securities and funds) in the custody of broker-dealers is adequately safeguarded.
By law, both of these rules apply to the activities of registered broker-dealers, but not to unregistered affiliates. The firm began operating as a (k)(2)(i)
broker dealer in November 2017 following notification to the Financial Industry Regulatory Authority and the SEC. A company operating under the (k)(2)
(i) exemption is not required to lock up customer funds as would otherwise be required under Exchange Act Rule 15c3-3.
ITEM 3. 	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are subject to various market risks, including those caused by changes in interest rates, credit, foreign currency exchange rates and equity prices. There
have not been material changes in our exposure to market risk since December 31, 2025. Refer to Item 7A. of CME Group’s Annual Report on Form 10-K
for the year ended December 31, 2025, filed with the SEC on February 26, 2026, for additional information.
ITEM 4. 	CONTROLS AND PROCEDURES
(a) Disclosure Controls and Procedures. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated
the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end
of the period covered by this report. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end
of such period, our disclosure controls and procedures are effective.
(b) Changes in Internal Control Over Financial Reporting. As required by Rule 13a-15(d) under the Exchange Act, the company’s management, including
the company’s Chief Executive Officer and Chief Financial Officer, have evaluated the company’s internal control over financial reporting (as such term is
defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to determine whether any changes occurred during the quarter covered by this quarterly
report that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting. There were no
changes in the company’s internal control over financial reporting which occurred during the fiscal quarter ended June 30, 2026, that have materially
affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1. 	LEGAL PROCEEDINGS
The disclosure under “Legal and Regulatory Matters” in Note 7. Contingencies in the Notes to Unaudited Consolidated Financial Statements in Item 1 of
Part I of this report is incorporated herein by reference. Such disclosure includes updates to the legal proceedings disclosed in the company’s Annual
Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.
ITEM 1A. 	RISK FACTORS
There have been no material changes in the company's risk factors from those disclosed in the company's Annual Report on Form 10-K for the year ended
December 31, 2025, filed with the SEC on February 26, 2026.
32

-- 32 of 38 --

Table of Contents
ITEM 2. 	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
Period Total Number of Shares
(or Units) Purchased
Average Price
Paid Per Share (or
Unit)
Total Number of
Shares (or Units) Purchased
as
Part of Publicly
Announced
Plans or Programs
Maximum Number (or
Approximate Dollar Value)
of Shares (or Units) that May Yet
Be Purchased Under
the Plans or Programs (in
millions)
April 1 to April 30 	740,654 (2) $ 	291.64 	740,623 $ 	1,983.8
May 1 to May 31 	638,435 (3) 	288.25 	638,313 	1,799.8
June 1 to June 30 	1,167,853 (4) 	253.14 	1,167,348 	1,504.4
Total 	2,546,942 (5) 	2,546,284
(1) CME Group maintains a share repurchase program under which CME Group is authorized to repurchase up to $3.0 billion of its outstanding Class
A common stock, par value $0.01 per share (the common stock) as announced on December 5, 2024. The share repurchase program has no
expiration date.
(2) Includes an aggregate of 31 shares of Class A common stock surrendered to satisfy employees' tax obligations upon the vesting of restricted stock.
(3) Includes an aggregate of 122 shares of Class A common stock surrendered to satisfy employee's tax obligations upon the vesting of restricted
stock.
(4) Includes an aggregate of 505 shares of Class A common stock surrendered to satisfy employee's tax obligations upon the vesting of restricted
stock.
(5) Shares purchased includes an aggregate of 658 shares of Class A common stock surrendered to satisfy employee tax obligations upon the vesting
of restricted stock.
ITEM 5. 	OTHER INFORMATION
On June 1, 2026, Jonathan Marcus, Senior Managing Director and General Counsel, adopted a trading plan intended to satisfy the affirmative defense of
Rule 10b5-1(c). Under the terms of the plan, Mr. Marcus is scheduled to sell an aggregate of up to 1,294 shares of the company's Class A common stock,
net of shares withheld to cover taxes, arising from restricted stock awards vesting on September 15, 2026 and March 15, 2027. The plan expires on the
earlier of March 23, 2027 or the completion of all authorized transactions under the plan.
(1) 	(1) 	(1)
33

-- 33 of 38 --

Table of Contents
ITEM 6. 	EXHIBITS
3.1 	Seventeenth Amended and Restated Bylaws of CME Group Inc. (incorporated by reference to Exhibit
3.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on December 9, 2022).
3.2 	Fourth Amended and Restated Certificate of Incorporation of CME Group Inc., as amended
(incorporated by reference to Exhibit 3.2 to CME Group Inc.'s Current Report on Form 8-K, filed with
the SEC on November 4, 2021).
10.1 	Amendment No. 11 to Credit Agreement, dated as of April 22, 2026, among Chicago Mercantile
Exchange Inc., certain lenders, Bank of America, N.A., as Administrative Agent, and Citibank, N.A.,
as Collateral Agent and Collateral Monitoring Agent. (incorporated by reference to Exhibit 10.1 to
CME Group Inc.'s Current Report on Form 8-K filed with the SEC on April 27, 2026)
10.2 	Transition and Executive Chairman Agreement, dated June 16, 2026, between CME Group Inc. and
Terrence A. Duffy. (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Current Report on
Form 8-K filed with the SEC on June 17, 2026)
10.3 	Employment Agreement, dated June 16, 2026, between CME Group, Inc. and Lynne C. Fitzpatrick.
(incorporated by reference to Exhibit 10.2 to CME Group Inc.'s Current Report on Form 8-K filed
with the SEC on June 17, 2026)
31.1 	Section 302 Certification—Terrence A. Duffy
31.2 	Section 302 Certification—Lynne Fitzpatrick
32.1 	Section 906 Certification
101 	The following materials from CME Group Inc.’s Quarterly Report on Form 10-Q for the quarterly
period ended June 30, 2026, formatted in Inline XBRL (Xtensible Business Reporting Language): (i)
the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated
Statements of Comprehensive Income, (iv) the Consolidated Statements of Equity, (v) the
Consolidated Statements of Cash Flows and (vi) Notes to Unaudited Consolidated Financial
Statements, tagged as blocks of text.
104 	Cover Page Interactive Data File included in the Inline XBRL Document Set for Exhibit 101.
101.DEF 	XBRL Taxonomy Extension Definition Linkbase
101.LAB 	XBRL Taxonomy Extension Label Linkbase Document
101.PRE 	XBRL Taxonomy Extension Presentation Linkbase Document
34

-- 34 of 38 --

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
CME Group Inc.
(Registrant)
Dated: July 24, 2026 	By: 	/s/ Lynne Fitzpatrick
Lynne Fitzpatrick
Senior Managing Director, President and Chief Financial Officer
Principal Financial Offer and
Duly Authorized Officer
35

-- 35 of 38 --

Exhibit 31.1
CERTIFICATION
I, Terrence A. Duffy, certify that:
1. I have reviewed this report on Form 10-Q of CME Group Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal
quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely
to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over
financial reporting.
Dated: July 24, 2026 	/s/ Terrence A. Duffy
Name: Terrence A. Duffy
Title: Chief Executive Officer

-- 36 of 38 --

Exhibit 31.2
CERTIFICATION
I, Lynne Fitzpatrick, certify that:
1. I have reviewed this report on Form 10-Q of CME Group Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal
quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely
to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over
financial reporting.
Dated: July 24, 2026 	/s/ Lynne Fitzpatrick
Name: Lynne Fitzpatrick
Title: President and Chief Financial Officer

-- 37 of 38 --

Exhibit 32.1
Certification of CEO and CFO Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report on Form 10-Q of CME Group Inc. (the “Company”) for the quarter ended June 30, 2026 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), Terrence A. Duffy, as Chief Executive Officer of the Company, and Lynne
Fitzpatrick, as President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of
the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.
/s/ Terrence A. Duffy
Name: Terrence A. Duffy
Title: Chief Executive Officer
Dated: July 24, 2026
/s/ Lynne Fitzpatrick
Name: Lynne Fitzpatrick
Title: President and Chief Financial Officer
Dated: July 24, 2026
This certification accompanies the Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by § 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

-- 38 of 38 --